Seung Min Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seung Min Lee has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Amna Parveen
College of Pharmacy, Gachon University, Incheon, Republic of Korea
1 shared publication - Sultana Razia
Department of Pharmacy, Jagannath University, 9-10, Chittarnajan Avenue, Dhaka-1100, Bangladesh
1 shared publication - Sun Yeou Kim
Laboratory of Pharmacognosy, College of Pharmacy, Gachon University, Incheon 21936, Republic of Korea
1 shared publication - Tae Hun Kim
College of Pharmacy, Gachon University, Inchon, Korea
1 shared publication
Latest Publications
- 9 April 2021
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 44 (4) , 378-401
Phytochemicals against anti‐diabetic complications: targeting the advanced glycation end product signaling pathway
The role of advanced glycation end products (AGEs) is not limited to diabetes and diabetes-related complications. There are multiple modulators, including the receptor for advanced glycation end products, high mobility group box 1, glyoxalase 1, nuclear factor-kappa B, tumor necrosis factor-α, chronic unpredictable stress, reactive oxygen species, and inflammatory cytokines, which interact with AGE signaling and control diabetes, modulating these interacting modulators. The progression of diabetes, as well as related complications, can be controlled and treated. Natural products rich in bioactive constituents can interact with AGEs and their related mediators through various signaling cascades, thereby controlling and preventing the progression of diabetes. This review provides a deeper assessment of the signaling pathway, interactions between phytochemicals and AGEs, and its mediators, to develop a multifold therapeutic approach to prevent and treat diabetes and its related complications.
- 9 April 2021
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 44 (4) , 378-401
Phytochemicals against anti‐diabetic complications: targeting the advanced glycation end product signaling pathway
The role of advanced glycation end products (AGEs) is not limited to diabetes and diabetes-related complications. There are multiple modulators, including the receptor for advanced glycation end products, high mobility group box 1, glyoxalase 1, nuclear factor-kappa B, tumor necrosis factor-α, chronic unpredictable stress, reactive oxygen species, and inflammatory cytokines, which interact with AGE signaling and control diabetes, modulating these interacting modulators. The progression of diabetes, as well as related complications, can be controlled and treated. Natural products rich in bioactive constituents can interact with AGEs and their related mediators through various signaling cascades, thereby controlling and preventing the progression of diabetes. This review provides a deeper assessment of the signaling pathway, interactions between phytochemicals and AGEs, and its mediators, to develop a multifold therapeutic approach to prevent and treat diabetes and its related complications.